Veracyte, Inc.
VCYT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,029 | $1,998 | $1,698 | $2,797 |
| - Cash | $239 | $216 | $154 | $173 |
| + Debt | $51 | $13 | $15 | $19 |
| Enterprise Value | $2,840 | $1,795 | $1,558 | $2,643 |
| Revenue | $446 | $361 | $297 | $220 |
| % Growth | 23.5% | 21.8% | 35.1% | – |
| Gross Profit | $298 | $248 | $195 | $145 |
| % Margin | 66.9% | 68.7% | 65.7% | 66.1% |
| EBITDA | $49 | -$49 | -$7 | -$60 |
| % Margin | 11% | -13.7% | -2.4% | -27.4% |
| Net Income | $24 | -$74 | -$37 | -$76 |
| % Margin | 5.4% | -20.6% | -12.3% | -34.4% |
| EPS Diluted | 0.31 | -1.02 | -0.51 | -1.11 |
| % Growth | 130.4% | -100% | 54.1% | – |
| Operating Cash Flow | $75 | $44 | $8 | -$32 |
| Capital Expenditures | -$11 | -$10 | -$9 | -$5 |
| Free Cash Flow | $64 | $34 | -$1 | -$37 |